Pommier R F, Vetto J T, Billingsly K, Woltering E A, Brennan M F
Department of Surgery, Oregon Health Sciences University, Portland 97201.
Surgery. 1993 Dec;114(6):1160-5; discussion 1165-6.
It is commonly believed that extraadrenal tumors (EAT) of the paraganglion system are more likely to be malignant than adrenal tumors (AT) and carry a poorer prognosis. We analyzed 73 paraganglion tumors (PT) to determine whether EATs are more likely to be malignant or have a poorer prognosis than ATs.
A review of patients with PTs at three institutions was performed. Malignant tumors were defined as those that metastasized. Comparison of the frequencies of malignant tumors was performed by chi-squared analysis. Survival distributions were determined by Kaplan and Meier analysis. Comparison of survival distributions was performed by log-rank analysis.
There were 73 patients. There were 51 ATs, of which 24 were malignant, and 22 EATs, of which 11 were malignant (p = 0.82). The 5-year survival rate was 77% for patients with ATs and 82% for patients with EATs (p = 0.29). The 5-year survival rate for patients with malignant ATs was 57%, and 74% for patients with malignant EATs (p = 0.15). There were no significant differences in disease-free survival rates on the basis of tumor site.
We were unable to demonstrate that EATs are significantly more likely to be malignant than ATs. The survival and disease-free survival rates for malignant ATs and EATs are similar, and among malignant tumors, there may be no prognostic value of the anatomic location.
人们普遍认为,副神经节系统的肾上腺外肿瘤(EAT)比肾上腺肿瘤(AT)更有可能是恶性的,且预后更差。我们分析了73例副神经节肿瘤(PT),以确定EAT是否比AT更有可能是恶性的或预后更差。
对三个机构的PT患者进行了回顾性研究。恶性肿瘤定义为发生转移的肿瘤。通过卡方分析比较恶性肿瘤的发生率。生存分布通过Kaplan-Meier分析确定。生存分布的比较通过对数秩分析进行。
共有73例患者。其中有51例AT,其中24例为恶性;22例EAT,其中11例为恶性(p = 0.82)。AT患者的5年生存率为77%,EAT患者为82%(p = 0.29)。恶性AT患者的5年生存率为57%,恶性EAT患者为74%(p = 0.15)。基于肿瘤部位的无病生存率无显著差异。
我们无法证明EAT比AT更有可能是恶性的。恶性AT和EAT的生存率和无病生存率相似,在恶性肿瘤中,解剖位置可能没有预后价值。